- Home
- TLSI vs MPAA Comparison
TLSI vs MPAA Comparison
Compare TLSI & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MPAA
- Stock Information
- Founded
- TLSI 2010
- MPAA 1968
- Country
- TLSI United States
- MPAA United States
- Employees
- TLSI N/A
- MPAA N/A
- Industry
- TLSI Medical Specialities
- MPAA Auto Parts:O.E.M.
- Sector
- TLSI Health Care
- MPAA Consumer Discretionary
- Exchange
- TLSI Nasdaq
- MPAA Nasdaq
- Market Cap
- TLSI 158.0M
- MPAA 154.5M
- IPO Year
- TLSI N/A
- MPAA 1994
- Fundamental
- Price
- TLSI $5.77
- MPAA $10.44
- Analyst Decision
- TLSI Strong Buy
- MPAA
- Analyst Count
- TLSI 6
- MPAA 0
- Target Price
- TLSI $11.75
- MPAA N/A
- AVG Volume (30 Days)
- TLSI 40.4K
- MPAA 154.0K
- Earning Date
- TLSI 03-27-2025
- MPAA 02-10-2025
- Dividend Yield
- TLSI N/A
- MPAA N/A
- EPS Growth
- TLSI N/A
- MPAA N/A
- EPS
- TLSI N/A
- MPAA N/A
- Revenue
- TLSI $26,891,000.00
- MPAA $753,727,000.00
- Revenue This Year
- TLSI $61.29
- MPAA $7.30
- Revenue Next Year
- TLSI $53.21
- MPAA $5.96
- P/E Ratio
- TLSI N/A
- MPAA N/A
- Revenue Growth
- TLSI 67.90
- MPAA 4.26
- 52 Week Low
- TLSI $3.50
- MPAA $4.36
- 52 Week High
- TLSI $10.42
- MPAA $11.50
- Technical
- Relative Strength Index (RSI)
- TLSI 68.94
- MPAA 72.04
- Support Level
- TLSI $5.40
- MPAA $5.38
- Resistance Level
- TLSI $5.82
- MPAA $11.50
- Average True Range (ATR)
- TLSI 0.24
- MPAA 0.87
- MACD
- TLSI 0.01
- MPAA 0.47
- Stochastic Oscillator
- TLSI 89.19
- MPAA 82.68
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.